Medindia
Medindia LOGIN REGISTER
Advertisement

Zila To Present at Roth 2007 New York Conference

Tuesday, August 28, 2007 General News
Advertisement
PHOENIX, Aug. 28 Zila, Inc. (Nasdaq: ZILA) todayannounced that Frank J. Bellizzi, DMD, president of Zila Pharmaceuticals, willpresent a company overview at the Roth 2007 New York Conference on Wednesday,September 5, 2007 at 4:30 p.m. ET at The Westin New York Hotel at TimesSquare.
Advertisement

Interested parties can listen to the presentation through a live webcastat the Zila Web site, www.zila.com. Listeners are encouraged to visit the Website at least 15 minutes prior to the start of the scheduled presentation toregister, download and install any necessary audio software. For those unableto listen to the live webcast, the presentation will be archived on the sameWeb site for approximately 90 days.
Advertisement

About Zila, Inc.

Zila, Inc., headquartered in Phoenix, is an oral cancer screening companyfocused on the prevention and treatment of oral disease.

Zila is dedicated to establishing ViziLite(R) Plus as the new standard ofcare for the early detection of oral abnormalities that could lead to cancer,with an initial focus on the dental market through Pro-Dentec(R), a leadingdesigner, manufacturer and marketer of Soft Tissue Management (STM(R))products. Sold exclusively and directly to dental professionals, Pro-Dentec'score products include the Rota-dent(R) Professional Powered Brush, the Pro-Select3(R) Piezo-Ultrasonic Scaler System and a suite of pharmaceutical STM(R)products for both in-office and home-care use.

For more information about Zila, visit www.zila.com.

SOURCE Zila, Inc.
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close